24 F. Supp. 3d 889 | N.D. Cal. | 2014
ORDER DENYING MOTION TO DISMISS
I. INTRODUCTION
This putative class action complaint challenges use of the term “evaporated cane juice” by Yucatan Foods, L.P..(“Yucatan”) on the labels of several of its products, all of which are alleged to carry identically misleading labels in violation of California’s Sherman Law and Unfair Competition Law. Yucatan moves to dismiss on the grounds that (1) plaintiffs cannot plead federal jurisdiction based on class action status; (2) plaintiffs’ claims are preempted by federal law; (3) the subject matter falls within the primary jurisdiction of the Food and Drug Administration. (“FDA”); (4) plaintiffs lack standing to sue; and (5) plaintiffs fail to state a plausible claim under the UCL. For the reasons explained below, Yucatan’s motion to dismiss is denied.
II. BACKGROUND
Plaintiffs allege Yucatan has sold various misbranded products in violation of California’s Sherman Food, Drug, and Cosmetics Law, Cal. Health & Safety Code
The Sherman Law makes it unlawful to sell or offer for sale any food that is “mis-branded,” § 110760, a term defined solely in reference to the federal regulations: “Any food is misbranded if its labeling does not conform with the requirements for nutrition labeling as set forth in [21 U.S.C. Sec. 343(q) ] and the regulations adopted pursuant thereto.” § 110665. The Sherman Law further provides, “Any food fabricated from two or more ingredients is misbranded unless it bears a label clearly stating the common or usual name of each ingredient ....” § 110725(a): These two sections mirror the federal provision that a food is misbranded “[ujnless its label bears (1) the common or usual name of the food, if any there be, and (2) in case it is fabricated from two or more ingredients, the common or usual name of each such ingredient....” 21 U.S.C. § 343(i).
Section 110725 instructs the state department to “take into consideration” the current federal regulations in adopting any state regulations pursuant to that section, but it is not limited thereto. § 110725(c). Nevertheless, plaintiffs do not cite to any independent state labeling regulations to allege that Yucatan’s use of the term “evaporated cane juice” is “unlawful” to support their UCL claim. Instead, plaintiffs’ claim relies solely on the federal regulations issued pursuant to the Nutrition Labeling and Education Act of 1990 (“NLEA”), 21 U.S.C. § 343-1. Plaintiffs point to 21 C.F.R. §§ 101.3, (prohibiting manufacturers from referring to foods by anything other than their common and usual names), 102.5 (same), and § 101.4 (prohibiting manufacturers from referring to ingredients by anything other than their common and usual names) to define what they allege is “unlawful” labeling activity
Although the FDA regulations do not specifically address the term “evaporated cane juice,” the agency did publish draft guidance in 2009, observing:
Over the past few years the term “evaporated cane juice” has started to appear as an ingredient on food labels, most commonly to declare the presence of sweeteners derived from sugar cane syrup. However, FDA’s current policy is that sweeteners derived from sugar cane syrup should not be declared as ‘evaporated cane juice’ because that term falsely suggests that the sweeteners are juice.
FDA, Draft Guidance for Industry, 2009 WL 3288507, at *1 (Oct. 1, 2005) (“2009 Draft Guidance”). The 2009 Draft Guidance concludes:
The intent of this draft guidance is to advise the regulated industry of FDA’s view that the term “evaporated cane juice” is not the common or usual name of any type of sweetener, including dried cane syrup. Because cane syrup has a standard of identity defined by regulation in 21 CFR 168.130, the common or usual name for the solid or dried form of cane syrup is “dried cane syrup.”
Sweeteners derived from sugar cane syrup should not be listed in the ingredient declaration by names which suggest that the ingredients are juice, such as “evaporated cane juice.” FDA considers such representations to be false and misleading under section 403(a)(1) of the Act (21 U.S.C. 343(a)(1)) because they fail to reveal the basic nature of the food and its characterizing properties (i.e., that the ingredients are sugars or syrups) as required by 21 CFR 102.5.
2009 WL 3288507, *2-3. The FDA has not issued final guidance on this point, but it has issued several warning letters to producers cautioning against the use of the term “evaporated cane juice.” (See, e.g., Plaintiffs RJN, Exh. C-F.) Some of these warning letters were issued after the draft guidance was published. (See, e.g., Plaintiffs RJN, Exh. E, F.)
III. LEGAL STANDARDS
A complaint must contain “a short and plain statement of the claim showing that the pleader is entitled to relief.” Fed.R.Civ.P. 8(a)(2). While “detailed factual allegations are not required,” a complaint must include sufficient facts to “state a claim to relief that is plausible on its face.” Ashcroft v. Iqbal, 556 U.S. 662, 678, 129 S.Ct. 1937, 173 L.Ed.2d 868 (2009) (citing Bell Atlantic Corp. v. Twombly, 550 U.S. 544, 570, 127 S.Ct. 1955, 167 L.Ed.2d 929 (2007)). A claim is facially plausible “when the plaintiff pleads factual content that allows the court to draw the reasonable inference that the defendant is liable for the misconduct alleged.” Id. A motion to dismiss a complaint under Rule 12(b)(6) of the Federal Rules of Civil Procedure tests the legal sufficiency of the claims alleged in the complaint. See Parks Sch. of Bus.
IV. DISCUSSION
A. Federal Jurisdiction
As an initial matter, Yucatan argues plaintiffs fail to plead a claim invoking federal jurisdiction. Plaintiffs assert federal jurisdiction pursuant to the Class Action Fairness Act (CAFA), which vests the district courts with jurisdiction over class actions in which the amount in controversy exceéds $5 million so long as there is minimal diversity between the parties. 28 U.S.C. § 1332(d)(2). Nevertheless, Yucatan argues the so-called “home state” exception should apply, under which the court “shall” decline jurisdiction when both the primary defendants and two thirds of the proposed plaintiff class members are citizens of the forum state. 28 U.S.C. § 1332(d)(4).
Ordinarily, the party seeking to invoke federal diversity jurisdiction must bear the burden of establishing that the court may properly exercise such jurisdiction. Kohler v. Inter-Tel Techs., 244 F.3d 1167, 1170 n. 3 (9th Cir.2001). However, the “home state” provision of subdivision (d)(4) is an exception to jurisdiction under CAFA and therefore not part of the prima facie case for establishing minimal diversity jurisdiction. Serrano v. 180 Connect, Inc., 478 F.3d 1018, 1023 (9th Cir.2007). “[Ajlthough the removing party bears the initial burden of establishing federal jurisdiction under § 1332(d)(2), once federal jurisdiction has been established under that provision, the objecting party bears the burden of proof as to the applicability of any express statutory exception under §§ 1332(d)(4)(A) and (B).” Serrano, 478 F.3d at 1024.
On its face, plaintiffs’ complaint meets the jurisdictional requirements of § 1332(d)(2). Defendant is a Delaware corporation with its headquarters in Los Angeles, California. Plaintiffs assert claims on behalf of over 100 members of a proposed class of consumers throughout the United States, including class members from states other than Delaware or California and an amount in controversy in excess of $5 million in the aggregate. These assertions, unchallenged by Yucatan, are sufficient to establish a prima facie case for minimal diversity jurisdiction under CAFA.
The burden then shifts to Yucatan, which argues the “home state” exception applies despite plaintiffs’ allegations regarding a nationwide class of consumers. Yucatan points to a California appellate decision reversing the trial court’s certification of a nationwide UCL consumer class on the ground that the UCL was not intended to regulate conduct unconnected to California. Norwest Mortgage, Inc. v. Su
B. Preemption
Pursuant to the Supremacy Clause, federal law preempts state law when: “(1) Congress enacts a statute that explicitly pre-empts state law; (2) state law actually conflicts with federal law; or (3) federal law occupies a legislative field to such an extent it is reasonable to conclude that Congress left no room for state regulation in that field.” Chae v. SLM Corp., 593 F.3d 936, 941 (9th Cir.2010). There is a presumption against preemption “unless that [is] the clear and manifest purpose of Congress,” United States v. Locke, 529 U.S. 89, 107, 120 S.Ct. 1135, 146 L.Ed.2d 69 (2000). This presumption is heightened where “federal law is said to bar state action in fields of traditional state regulation.” N.Y. State Conference of Blue Cross & Blue Shield Plans v. Travelers Ins. Co., 514 U.S. 645, 655, 115 S.Ct. 1671, 131 L.Ed.2d 695 (1995). In light of the historical “primacy of state regulation of matters of health and safety,” Medtronic, Inc. v. Lohr, 518 U.S. 470, 485, 116 S.Ct. 2240, 135 L.Ed.2d 700 (1996), courts can assume that “state and local regulation related to [such] matters ... can normally coexist with federal regulations.” Hillsborough County v. Automated Med. Labs., Inc., 471 U.S. 707, 718, 105 S.Ct. 2371, 85 L.Ed.2d 714 (1985). Where Congress does provide for express preemption, the presumption against preemption requires courts to read the clause narrowly. Medtronic, 518 U.S. at 485, 116 S.Ct. 2240.
Yucatan first argues the FDCA explicitly preempts plaintiffs’ UCL claim. The NLEA states that it “shall not be construed to preempt any provision of State law, unless such provision is expressly preempted under [21 U.S.C. § 343-l(a) ] of the • [FDCA].” Pub.L. No. 101-535, § 6(e)(1). It does contain two express preemption provisions relating to sections 343(q) and (r). Section 343-l(a)(4) expressly preempts any state or local “requirement for nutrition labeling of food that is not identical to the requirement of section 343(q).” Section 343 — 1(a)(5), in turn, preempts state or local governments from imposing any requirement on nutrient content claims made by a food purveyor “in the label or labeling of food that is not identical to the requirement of section 343(r).” Where a requirement imposed by state law effectively parallels or mirrors the relevant sections of the NLEA, courts have repeatedly refused to find preemption. See, e.g., N.Y. State Rest. Ass’n v. N.Y. Bd. of Health, 556 F.3d 114, 123 (2d Cir.2009); Chavez v. Blue Sky Natural Beverage Co., 268 F.R.D. 365, 370 (N.D.Cal.2010). This means that plaintiffs’
In the more common nutrient content claim under the UCL, plaintiffs allege some aspect of the defendant’s label is misleading or deceptive. Here, plaintiffs limit their claim to the “unlawful” prong of the UCL in an effort to simplify the case “by dispensing with questions of ‘reliance’ or the ‘reasonable consumer standard.’” Plaintiffs assert a theory of liability that rests solely on defendant’s alleged failure to comply with the nutritional labeling requirements of the FDCA as incorporated into California state law by the state’s Sherman Law. Because the claim rises or falls on defendant’s compliance with the FDCA, the express preemption clause of section 343-1 does not apply.
In the alternative, Yucatan argues the FDCA impliedly preempts any private action seeking to enforce food labeling regulations. While it is true there is no private enforcement under the NLEA, “[n]umerous courts in this District have rejected the same preemption arguments in similar food misbranding cases where the requirements under the Sherman Law (asserted here through the UCL) are identical to the requirements imposed under the FDCA.” Ang v. Bimbo Bakeries USA, Inc., No. 13-cv-01196, 2013 WL 5407039, *11 (N.D.Cal. Sept. 25, 2013). Although the claims in Ang were not limited, as here, to the “unlawful” prong of the UCL, the analysis is equally applicable here to plaintiffs’ more narrow claim.
C. Primary Jurisdiction
The primary jurisdiction doctrine applies when there is: “(1) [a] need to resolve an issue that (2) has been placed by Congress within the jurisdiction of an administrative body having regulatory authority (3) pursuant to a statute that subjects an industry or activity to a comprehensive regulatory authority that (4) requires expertise or uniformity in administration.” Clark v. Time Warner, 523 F.3d 1110, 1115 (9th Cir.2008). “In practice, this means that the court either stays proceedings or dismisses the case without prejudice, so that the parties may seek an administrative ruling.” Id. at 1115. The doctrine of primary jurisdiction may only be properly invoked “in a limited set of circumstances”; it “is not designed to ‘secure expert advice’ from agencies every time a court is presented with an issue conceivably within the agency’s ambit.” Id. at 1114 (internal quotations omitted). “It is to be used only if a claim requires resolution of an issue of first impression, or of a particularly complicated issue that Congress has committed to a regulatory agency.” Id. (internal quotations omitted).
Yucatan argues that primary jurisdiction should apply because the FDA does not currently have a final position on the issue of “evaporated cane juice” labeling and is in the process of developing one. The FDA’s 2009 Draft Guidance on the use of the term “evaporated cane juice” specified the document was “nonbinding,” “do[es] not establish legally enforceable responsibilities,” and was circulated for the purpose of soliciting comments only. 2009 WL 3288507, at *1; see also 74 Fed.Reg. 51610-01 (Oct. 7, 2009) (explaining that draft guidance documents do not “create or confer any rights for or on any person and does not operate to bind FDA or the public”). Courts in this district have divided on whether the lack of formal guidance concerning “evaporated can juice” warrants application of primary jurisdiction. Compare Samat v. Proctor & Gamble Co.,
Although the FDA has not issued any final guidance directly addressing the term “evaporated cane juice,” it has provided guidance in the form of regulations concerning the terms “sugar,” “juice,” and “cane syrup” such that the issue presented here is hardly one of “first impression” necessitating its commitment to the agency. The fact that the FDA has not yet finalized the draft guidance issued more than four years ago, and that it continues to issue warning letters consistent with that position, further suggests the agency does not view the issue as unsettled.
D. Standing
Yucatan next argues plaintiffs lack standing to assert a claim for relief under the UCL. As the party seeking to invoke the Court’s jurisdiction, plaintiffs bear the burden of establishing constitutional standing and therefore subject matter jurisdiction over their claim. See Kokkonen v. Guardian Life Ins. Co. of America, 511 U.S. 375, 377, 114 S.Ct. 1673, 128 L.Ed.2d 391 (1994). “For purposes of ruling on a motion to dismiss for want of standing, both the trial and reviewing courts must accept as true all material allegations of the complaint and must construe the complaint in favor of the complaining party.” Warth v. Seldin, 422 U.S. 490, 501, 95 S.Ct. 2197, 45 L.Ed.2d 343 (1975).
To satisfy the United ' States Constitution’s standing requirement, “a plaintiff must show (1) it has suffered an ‘injury in fact’ that is (a) concrete and particularized and (b) actual or imminent, not conjectural or hypothetical; (2) the injury is fairly traceable to the challenged action of the defendant; and (3) it is likely, as opposed to merely speculative, that the injury will be redressed by a favorable decision.” Friends of the Earth, Inc. v. Laidlaw Envtl. Servs. (TOC) Inc., 528 U.S. 167, 180-81, 120 S.Ct. 693, 145 L.Ed.2d 610 (2000). Here, plaintiffs allege putative class members paid a premium price for Yucatan’s products labeled as containing “evaporated cane juice” and were thereby damaged “in that they purchased misbranded and worthless products that were illegal to sell or possess based on Defendant’s illegal labeling of the products.” (Compl.1ffl 31, 32.) This is enough at least as to those products actually purchased by plaintiffs. Yucatan’s counterarguments regarding the nature and degree of plaintiffs’ injury, and whether their labels were accurate or not, go to the merits of plaintiffs’ claim, not standing.
As to those class products which plaintiffs themselves did not purchase, that issue was considered at length in a recent case from this district. See Clancy, 2013 WL 4081632, *3-6. The Supreme Court has noted “there is tension in [its] prior
As Clancy recounts, decisions from within this District have split into three groups: (1) a strict position in which claims relating to products not purchased must be dismissed for lack of standing; (2) a middle ground in which the inquiry is whether there is sufficient similarity between the products which were purchased and those which were not; and (3) a third group finding standing to be satisfied so long as the named plaintiff has individual standing to bring claims regarding the purchased products and reserving the question of whether a proposed class can bring claims related to other products until the class certification stage. Clancy, at *4. Clancy adopts the third position.
It is not necessary here to parse the distinction between the second and third approach outlined in Clancy because plaintiffs challenge only the propriety of the term “evaporated cane juice,” a term indisputably present in the ingredient list of each of the class products. Plaintiffs’ claim rises or falls on whether the challenged term violates the FDA’s food labeling regulations and therefore renders the class products “unlawful” under the UCL.
Nevertheless, Yucatan argues for the most restrictive view of standing, for three reasons:
First, if there are regionality questions by products being purchased, that will be a factor determining whether a class action is appropriate at all.... Secondly, expanding class action cases to include numerous products not purchased by Plaintiffs would artificially expand the scope of a case, which will not be redressed until much later at the class certification stage, something that is not always financially viable for small companies such as Yucatan Foods. Third, complying with this requirement is hardly difficult, since plaintiffs that have in fact purchased the other products should not be hard to identify, if indeed the heart of the case has merit.
(Reply at 9.) None of these arguments rebut plaintiffs’ satisfaction of the case and controversy requirement of Article III nor implicate the traditional prudential concerns of standing. The first argument suggests plaintiffs may have a more difficult path to class certification — a consideration best left to the certification stage. The second concern, though well-taken, can be addressed through careful case management and the supervision of discovery. The third suggests that the issue is not one that would otherwise evade review, but that is no reason to foreclose claims asserted on behalf of other purported class members- at this juncture.
As in Clancy, it is not necessary to determine, at this point, that plaintiffs cannot represent a class who purchased any different products than did the plaintiffs. Clancy, *5. Importantly, as Clancy observed, plaintiffs here do not claim themselves to have standing to assert claims related to products they did not purchase, only that they may be potential representatives of a class of people who have such standing. Id. *6. Whether such a class may be certified, and whether these plaintiffs are determined to be adequate representatives, are questions for another day. On the facts as alleged in this case, the course adopted by Clancy seems appropriate, allowing plaintiffs to plead claims re
E. Plausibility
Plaintiffs rest their claim on the “unlawful” prong of the UCL, which defines unfair competition as “any unlawful, unfair or fraudulent business act or practice .... ” Cal. Bus. & Prof. Code § 17200. As explained by the state appellate court, “[TJhere are three varieties of unfair competition: practices which are unlawful, unfair or fraudulent.” In re Tobacco II Cases, 46 Cal.4th 298, 311, 93 Cal.Rptr.3d 559, 207 P.3d 20 (2009). “By proscribing ‘any unlawful’ business practice, section 17200 borrows violations of other laws and treats them as unlawful practices that the unfair competition law makes independently actionable.” Cel-Tech Communications, Inc. v. Los Angeles Cellular Telephone Co., 20 Cal.4th 163, 180, 83 Cal.Rptr.2d 548, 973 P.2d 527 (1999) (internal quotations and citations omitted).
Yucatan argues plaintiffs fail to state a plausible claim for relief because they fail to plead deception of the reasonable consumer or liability under the UCL. However, a plaintiff proceeding under the “unlawful” prong need only plead facts to show it is plausible the defendant broke the law because the legislature has already determined the conduct to be “unfair” by virtue of legislative prohibition. See, e.g., Morgan v. Wallaby, No. 13-296, 2013 WL 5514563, *8-9 (N.D.Cal. Oct. 4, 2013) (denying motion to dismiss as to unlawful prong of the UCL but granting as to unfair prong); Gitson v. Trader Joe’s Co,, No. 13-1333, 2013 WL 5513711, *8-10 (N.D.Cal. Oct. 4, 2013) (same). Plaintiffs, therefore, need not allege deception to proceed with this claim.
Because plaintiffs’ claim does not turn on a judicial finding of whether the term “evaporated cane juice” is misleading, but only on whether it is contrary to federal law and regulations, Yucatan’s argument that any possible deception is mitigated by the presence of “sugar” on the products’ nutrition facts panels is beside the point on this motion. Yucatan further argues plaintiffs fail to plead liability under the UCL because the complaint offers no “allegations to suggest that ECJ should be equated to plain ‘sugar’ or that ECJ’s use in the marketplace for roughly two decades has not established ‘ECJ’ as á common or usual name.” Plaintiffs’ allegations that “evaporated cane juice” is not a juice as defined by federal regulations nor the common or usual name for sugar are sufficient to state a plausible claim that Yucatan’s use of the term “evaporated cane juice” violates the federal regulations adopted by California pursuant to the Sherman Law.
To state a claim under the UCL, a plaintiff must also allege that he or she “has suffered injury in fact and has lost money or property as a result of the unfair competition.” Cal. Bus. & Prof.Code § 17204. Although Yucatan does not explicitly address this requirement, its arguments concerning standing could fairly be read to apply to this requirement. As above, plaintiffs’ allegations that they paid a premium price for the products and that Yucatan’s unlawful use of the term “evaporated cane juice” rendered them “worthless” is sufficient to state the requisite injury in fact and monetary loss required by § 17204. Yucatan’s motion to dismiss for failure to state a plausible claim is denied.
VI. CONCLUSION
The motion to dismiss is denied.
IT IS SO ORDERED.
. The Nutrition Labeling and Education Act of 1990 (“NLEA”), Pub.L. No. 101-535, amended the FDCA to set forth “uniform national standards for the nutritional claims and the required nutrient information displayed on food labels.” H.R.Rep. No. 101538, at *13 (1990), reprinted in 1990 U.S.C.C.A.N. 3336, 3342. Any reference to the FDCA in this order includes the NLEA amendments.
. Plaintiff alleges defendant sells a number of products with identical ECJ labels, including Authentic Guacamole, Mild Guacamole, Spicy Guacamole, Ranch Guacamole, Hummus Guacamole, and 2 oz. Singles Guacamole and the Guacamole Twinpack, all sold under the Yucatan Brand.
. “Alternatively, the word 'sirup' may be spelled 'syrup.' ” 21 C.F.R. § 168.130(c).
. According to the FDA July 2012 Regulatory Procedures Manual, "The agency position is that Warning Letters are issued only for violations of regulatory significance.” FDA, Regulatory Procedures Manual, 4-1 — Warning Letters (July 2012).